Meeting
2023 ASCO Quality Care Symposium
Development of provider ordered genetic testing pathway and electronic medical record best practice advisory (BPA) to aid in germline genetic testing for patients with metastatic breast cancer.
Authors
David Luis Ramirez
The University of Texas MD Anderson Cancer Center, Houston, TX
David Luis Ramirez, Jessica Corredor, Igryl Cordero-Hernandez, Banu Arun
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Quality Improvement Research and Implementation Science
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 443)
DOI
10.1200/OP.2023.19.11_suppl.443
Abstract #
443
Poster Bd #
K1
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Genetic counseling processes and outcomes among prostate cancer patients (ProGen).
First Author: Donna Rachel Vatnick
Poster
2023 ASCO Quality Care Symposium
Perceptions of emerging PARP inhibitor (PARPi) data among practicing oncologists in prostate cancer.
First Author: Nicholas Moffett
Poster
2023 ASCO Annual Meeting
Exactis-03: A phase I trial of the combination of olaparib and navitoclax in women with high grade serous ovarian cancer and triple negative breast cancer.
First Author: Helen Mackay
Poster
2023 ASCO Annual Meeting
Phase I/II study of stereotactic radiosurgery with concurrent olaparib followed by adjuvant durvalumab and physician’s choice systemic therapy in patients with breast cancer brain metastases.
First Author: Colette Shen